Financials
Financial year 2025
Worth noting
- More debts than assets in the latest financial year.
- A loss two years in a row.
- Little cash and receivables against the short-term debts.
Gross margin
€ -112,453
▲ 87% vs 2024
Profit
Caution€ -3.4 million
▲ 14% vs 2024
Debts
High€ 9.3 million
▲ 123% vs 2024
BIOXODES from Charleroi, company number BE0825151779, closed financial year 2025 with a result of € -3.4 million after tax. For that financial year BIOXODES recorded a gross margin of € -112,453 and equity of € -1.7 million. Compared with financial year 2024, the result moved from € -4 million to € -3.4 million. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 2, 2026.
What happened at BIOXODES?
What happened at BIOXODES in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- XMF SRL stepped down as director. NBB
- PHMBIO+ SRL stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 3.4 million. Source: NBB ↗
- CROUGHS R&D CONSULTING AUTRE stepped down as director. NBB
- Capital & Croissance SCRL stepped down as director. NBB
- Société Fédérale de Participations et d' Investissements SA stepped down as director. NBB
- PHMBIO+ SRL became a director. NBB
- XMF SRL became a director. NBB
In short
From € 2.2 million loss in 2021 to € 3.4 million loss in 2025.
Paid € 5,354 in corporate taxes since 2021.
On average € 110,500 of value added per employee in 2022.
A new publication or filing at BIOXODES? We notify you, reason included.
Follow BIOXODESNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Directors
According to the 2025 annual accounts
CROUGHS R&D CONSULTING AUTRE
Director · represented by Croughs Thérèse
since 2020 · until 2026
Director · represented by Pierre Detrixhe
Also active at: CONCEPTEXPO GROUP, COLONA, MEGAFORM +34 more
since 2020 · until 2026
Société Fédérale de Participations et d' Investissements SA
Director · represented by François Fontaine
Also active at: Aviapartner Belgium, Société Anonyme Belge de Constructions Aéronautiques, Société Nationale de Construction Aérospatiale +62 more
since 2020 · until 2026
Chairman of the board · represented by Monteyne Philippe
since 2025 · until 2026
Director · represented by Marc DECHAMPS
since 2022 · until 2028
Establishments
Establishment units
Physical locations of this company
Rue Santos - Dumont 1
6041 Charleroi
Rue Santos - Dumont 1-7
6041 Charleroi
Active since 20 April 2010
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
Details
- Company number
- 0825.151.779
- VAT number
- BE 0825.151.779
- Registered office
- Rue Santos - Dumont 1, 6041 Charleroi
- Names & denominations
- BIOXODES
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 20 April 2010
- Peppol
- Active · Active since 27 Mar 2026
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied